Who Exports Doxycycline from India — 408 Suppliers Behind a $118.6M Market
India's doxycycline export market is supplied by 408 active exporters who collectively shipped $118.6M across 5,999 shipments. ZYDUS LIFESCIENCES LIMITED leads with a 30.8% market share, followed by USV PRIVATE LIMITED and ALEMBIC PHARMACEUTICALS LIMITED. The top 5 suppliers together control 67.5% of total export value, reflecting a concentrated market structure.
Top Doxycycline Exporters from India — Ranked by Export Value
ZYDUS LIFESCIENCES LIMITED is the leading doxycycline exporter from India, holding a 30.8% share of the $118.6M market across 5,999 shipments from 408 exporters. The top 5 suppliers — ZYDUS LIFESCIENCES LIMITED, USV PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, MYLAN LABORATORIES LIMITED, AMNEAL PHARMACEUTICALS PRIVATE LIMITED — collectively control 67.5% of total export value, indicating a moderately concentrated market. Individual shares are: ZYDUS LIFESCIENCES LIMITED (30.8%), USV PRIVATE LIMITED (17.4%), ALEMBIC PHARMACEUTICALS LIMITED (9.5%), MYLAN LABORATORIES LIMITED (5.3%), AMNEAL PHARMACEUTICALS PRIVATE LIMITED (4.5%).
Top Doxycycline Exporters from India
Ranked by export value · 408 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $36.5M | 2 | 30.8% |
| 2 | USV PRIVATE LIMITED DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $20.6M | 1 | 17.4% |
| 3 | ALEMBIC PHARMACEUTICALS LIMITED DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $11.3M | 1 | 9.5% |
| 4 | MYLAN LABORATORIES LIMITED DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $6.3M | 3 | 5.3% |
| 5 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $5.3M | 1 | 4.5% |
| 6 | STRIDES PHARMA SCIENCE LIMITED APX-DOXYCYCLINE DOXYCYCLINE TABLETS [100DOXSIG DOXYCYCLINE TABLETS [100MG] 185,3APX-DOXYCYCLINE DOXYCYCLINE TABLETS [50M | $4.5M | 1 | 3.8% |
| 7 | CADILA HEALTHCARE LIMITED DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $4.5M | 1 | 3.8% |
| 8 | LUPIN LIMITED DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $3.5M | 1 | 2.9% |
| 9 | GLAND PHARMA LTD DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP US | $3.1M | 1 | 2.6% |
| 10 | GRACURE PHARMACEUTICALS LIMITED DOXY -200 TABLETS B/8 (DOXYCYCLINE MONOH | $1.8M | 1 | 1.5% |
| 11 | ZIM LABORATORIES LIMITED. DOXYZIM 100 (DOXYCYCLINE CAPSULES BP 100DOXYZIM 100DOXYZIM 100 DOXYCYCLINE CAPSULES BP 100MG | $1.8M | 2 | 1.5% |
| 12 | S KANT HEALTHCARE LIMITED DOXYCYCLINE TABLETS 50MG, 100S USDOXYCYCLINE HYCLATE TABUSP 50MG 60TAP USDOXYZIM 100 (DOXYCYCLINE CAPSULES BP 100 | $1.2M | 3 | 1.0% |
| 13 | MEDOPHARM PHARMACEUTICAL PRODUCTS: DOXYCYCLINE HYCMICRODOX DTAGIDOX 100 | $1.2M | 21 | 1.0% |
| 14 | MEPRO PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PRODUCTS: DOXYCYCLINE HYCPHARMA DRUGS & MEDI DOXYCYCLINE ACCORD 1 | $1.1M | 3 | 0.9% |
| 15 | BRAWN LABORATORIES LIMITED DOXYZIM 100 (DOXYCYCLINE CAPSULES BP 100DOXYCYCLINE CAPSULES 100MG NOSDOXYZIM 100 | $951.3K | 6 | 0.8% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Doxycycline exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Zydus Lifesciences Limited | Approved | Yes | Yes | Over 460 as of March 31, 2024 | Received FDA approval for Valsartan Tablets in July 2024; issued FDA warning let |
| Alembic Pharmaceuticals Limited | Approved | Yes | Yes | 223 as of August 2025 | Received multiple FDA approvals between 2024 and 2025, including for Rivaroxaban |
| Cadila Pharmaceuticals Limited | Approved | Yes | Yes | Not specified | FDA issued a cautionary notice in 2014 for manufacturing practice discrepancies |
TransData Nexus reviewed the regulatory standing of 3 leading Doxycycline exporters from India. 3 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 3 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Doxycycline sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes to more than 40% of the country's bulk drug production. This prominence is due to the presence of numerous Active Pharmaceutical Ingredient (API) manufacturers and bulk drug producers. Companies like SVK Laboratories Private Limited, established in 2007, specialize in the production of bulk drugs, drug intermediates, and fine chemicals. Their state-of-the-art facilities in Hyderabad ensure rigorous quality control and adherence to Good Manufacturing Practices (GMP). Additionally, Vasudha Pharma Chem Ltd., located in Jeedimetla, Hyderabad, is known for manufacturing bulk drugs and intermediates, further solidifying the city's status as a hub for API production.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Alembic Pharmaceuticals, headquartered in Vadodara, exemplifies this specialization. Founded in 1907, Alembic manufactures and markets a wide range of pharmaceutical products, including formulations for therapeutic areas such as cardiology, dermatology, diabetes, ophthalmology, and infectious diseases. The region's emphasis on formulations complements the bulk drug production in Hyderabad, creating a synergistic supply chain for drugs like Doxycycline.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. This region hosts numerous pharmaceutical companies with well-established export channels, facilitating the distribution of drugs like Doxycycline to international markets. The proximity to major ports and international airports enhances the efficiency of logistics and supply chain operations, ensuring timely delivery to global destinations.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, primarily due to favorable tax incentives offered by the government. This zone attracts numerous pharmaceutical companies seeking cost-effective production solutions. The presence of these manufacturers contributes to the overall supply chain of drugs like Doxycycline, offering additional sourcing options.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Assess Quality Compliance: Ensure that suppliers adhere to international quality standards, such as GMP and ISO certifications, to maintain product integrity.
- Evaluate Logistics Infrastructure: Consider the logistical capabilities of each region, including proximity to ports and transportation networks, to optimize supply chain efficiency.
- Monitor Regulatory Changes: Stay informed about regional tax incentives and regulatory policies that may impact production costs and supplier selection.
By strategically leveraging the strengths of India's pharmaceutical clusters, companies can enhance the reliability and efficiency of their Doxycycline supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Doxycycline exporters from India
Zydus Lifesciences Limited — Zydus acquires Agenus' Biologics CMC Facilities for $125M
Zydus Lifesciences Limited acquired the Biologics CMC Facilities from Agenus for $125 million, aiming to enhance its biologics manufacturing capabilities. - IMPACT: This acquisition is expected to bolster Zydus' production capacity, potentially increasing Doxycycline exports.
Impact: This acquisition is expected to bolster Zydus' production capacity, potentially increasing Doxycycline exports.
Zydus Lifesciences Limited — Zydus explores M&A and licensing to expand US specialty business
Zydus Lifesciences is considering mergers, acquisitions, and licensing agreements to strengthen its specialty portfolio in the US, particularly in preparation for the potential launch of its liver therapy drug, saroglitazar. - IMPACT: These strategic initiatives may lead to increased resources and focus on Doxycycline production, enhancing export capabilities.
Impact: These strategic initiatives may lead to increased resources and focus on Doxycycline production, enhancing export capabilities.
Alembic Pharmaceuticals Limited — Alembic partners with Amlan International for poultry health solutions
Alembic Pharmaceuticals entered into a strategic agreement with Amlan International to distribute mineral-based feed additives for poultry health in India. - IMPACT: While this collaboration focuses on animal health, it may indirectly affect Alembic's resource allocation for Doxycycline production, potentially influencing export volumes.
Impact: While this collaboration focuses on animal health, it may indirectly affect Alembic's resource allocation for Doxycycline production, potentially influencing export volumes.
Common Questions — Doxycycline Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which doxycycline supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ZYDUS LIFESCIENCES LIMITED leads with 78 recorded shipments worth $36.5M. USV PRIVATE LIMITED (126 shipments) and ALEMBIC PHARMACEUTICALS LIMITED (141 shipments) are also established high-volume exporters.
Q How many doxycycline manufacturers are there in India?
India has 408 active doxycycline exporters with a combined export market of $118.6M across 5,999 shipments to 149 countries. The top 5 suppliers hold 67.5% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for doxycycline from India?
Average FOB unit price: $53.40 per unit, ranging from $0.00 to $21698.56. Average shipment value: $19.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 408 verified Indian exporters of Doxycycline ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 5,999 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 149 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,999 Verified Shipments
408 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists